Reduced Expression of Plakoglobin Correlates with Adverse Outcome in Patients with Neuroblastoma
- 31 July 2001
- journal article
- research article
- Published by Elsevier in The American Journal of Pathology
- Vol. 159 (1) , 43-49
- https://doi.org/10.1016/s0002-9440(10)61671-9
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- From cadherins to catenins: cytoplasmic protein interactions and regulation of cell adhesionPublished by Elsevier ,2002
- A comparative evaluation of β-catenin and plakoglobin signaling activityOncogene, 2000
- Differential Mechanisms of LEF/TCF Family-Dependent Transcriptional Activation by β-Catenin and PlakoglobinMolecular and Cellular Biology, 2000
- N-Cadherin Promotes Motility in Human Breast Cancer Cells Regardless of Their E-Cadherin ExpressionThe Journal of cell biology, 1999
- Activation of β-Catenin-Tcf Signaling in Colon Cancer by Mutations in β-Catenin or APCScience, 1997
- Constitutive Transcriptional Activation by a β-Catenin-Tcf Complex in APC −/− Colon CarcinomaScience, 1997
- Malignant phenotype correlating with drug resistance in two human neuroblastoma cell linesJournal of Neuro-Oncology, 1994
- Cadherin expression in carcinomas: role in the formation of cell junctions and the prevention of invasivenessBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1994
- Plakoglobin: A protein common to different kinds of intercellular adhering junctionsCell, 1986
- Association of Multiple Copies of the N-mycOncogene with Rapid Progression of NeuroblastomasNew England Journal of Medicine, 1985